These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35478448)
1. Identification of B-cell dominant epitopes in the recombinant protein P29 from Echinococcus granulosus. Lv Y; Li S; Zhang T; Zhu Y; Tao J; Yang J; Chang L; Wu C; Zhao W Immun Inflamm Dis; 2022 May; 10(5):e611. PubMed ID: 35478448 [TBL] [Abstract][Full Text] [Related]
2. Optimizing sheep B-cell epitopes in Yang J; Lv Y; Zhu Y; Song J; Zhu M; Wu C; Fu Y; Zhao W; Zhao Y Front Immunol; 2024; 15():1451538. PubMed ID: 39206186 [TBL] [Abstract][Full Text] [Related]
3. Identification of a dominant murine T-cell epitope in recombinant protein P29 from Echinococcus granulosus. Lv Y; Zhu Y; Chang L; Yang J; Zhao Y; Zhao J; Wang Y; Zhu M; Wu C; Zhao W Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):482-493. PubMed ID: 35607954 [TBL] [Abstract][Full Text] [Related]
4. lncRNA028466 regulates Th1/Th2 cytokine expression and associates with Echinococcus granulosus antigen P29 immunity. Wang C; Yang SH; Niu N; Tao J; Du XC; Yang JH; Zhu MX; Wang YN; Zhao W Parasit Vectors; 2021 Jun; 14(1):295. PubMed ID: 34082780 [TBL] [Abstract][Full Text] [Related]
5. Immunoprotection of recombinant Eg.P29 against Echinococcus granulosus in sheep. Wang H; Li Z; Gao F; Zhao J; Zhu M; He X; Niu N; Zhao W Vet Res Commun; 2016 Jun; 40(2):73-9. PubMed ID: 27094043 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of peptide-based vaccine composed of epitopes from Echinococcus granulosus rEg.P29. Lv Y; Chang L; Yang J; Wen J; Zhao Y; Zhu M; Wu C; Zhao W FASEB J; 2023 Apr; 37(4):e22819. PubMed ID: 36848174 [TBL] [Abstract][Full Text] [Related]
7. Recombinant antigen P29 of Yang J; Zhao Y; Fu Y; Lv Y; Zhu Y; Zhu M; Zhao J; Wang Y; Wu C; Zhao W Front Immunol; 2023; 14():1243204. PubMed ID: 38187382 [No Abstract] [Full Text] [Related]
8. Clinical characteristics and antibodies against Echinococcus granulosus recombinant antigen P29 in patients with cystic echinococcosis in China. Tao J; Du X; Liu K; Wang C; Lv Y; Wang M; Yang Z; Yang J; Li S; Wu C; Li M; Zhao W BMC Infect Dis; 2022 Jul; 22(1):609. PubMed ID: 35820830 [TBL] [Abstract][Full Text] [Related]
9. Changes in intestinal flora of mice induced by rEg.P29 epitope peptide vaccines. Zhang T; Lv Y; Zhao Y; Yang J; Qian B; Zhu Y; Zhao W; Zhu M Immun Inflamm Dis; 2023 Nov; 11(11):e1082. PubMed ID: 38018604 [TBL] [Abstract][Full Text] [Related]
10. MiR-374b-5p Regulates T Cell Differentiation and Is Associated with rEg.P29 Immunity. Li D; Du X; Zhu M; Yang S; Zhao W Biomed Res Int; 2020; 2020():8024763. PubMed ID: 32908913 [No Abstract] [Full Text] [Related]
11. The Recombinant Du X; Zhu M; Zhang T; Wang C; Tao J; Yang S; Zhu Y; Zhao W Front Immunol; 2022; 13():773276. PubMed ID: 35211114 [No Abstract] [Full Text] [Related]
12. Immunoprotective effect and mechanism of rEg.P29 against CD4 Li M; Zhu Y; Li Z; Song J; Zhao W Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):482-489. PubMed ID: 38151996 [TBL] [Abstract][Full Text] [Related]
13. Preliminary Evaluation of Recombinant EPC1 and TPx for Serological Diagnosis of Animal Cystic Echinococcosis. Liang Y; Song H; Wu M; Xie Y; Gu X; He R; Lai W; Jing B; Peng X; Yang G Front Cell Infect Microbiol; 2020; 10():177. PubMed ID: 32426296 [TBL] [Abstract][Full Text] [Related]
14. Echinococcus P29 antigen: molecular characterization and implication on post-surgery follow-up of CE patients infected with different species of the Echinococcus granulosus complex. Boubaker G; Gottstein B; Hemphill A; Babba H; Spiliotis M PLoS One; 2014; 9(5):e98357. PubMed ID: 24851904 [TBL] [Abstract][Full Text] [Related]
15. Activity in mice of recombinant BCG-EgG1Y162 vaccine for Echinococcus granulosus infection. Ma X; Zhao H; Zhang F; Zhu Y; Peng S; Ma H; Cao C; Xin Y; Yimiti D; Wen H; Ding J Hum Vaccin Immunother; 2016; 12(1):170-5. PubMed ID: 26266551 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of EgA31 and EgG1Y162 proteins for designing a multi-epitope vaccine against Echinococcus granulosus. Zhao X; Zhang F; Li Z; Wang H; An M; Li Y; Pang N; Ding J Infect Genet Evol; 2019 Sep; 73():98-108. PubMed ID: 31022474 [TBL] [Abstract][Full Text] [Related]
17. [Cloning, Expression and Immungenicity Analysis of Antigen Eg-01883 Screened from Protoscoleces of Echinococcus granulosus]. Zhao YQ; Li ZH; Wang H; Zhu MX; Niu N; Wang YN; Zhao JQ; Li N; Tong XQ; Song JH; Zhao W Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2016 Jun; 34(3):208-13. PubMed ID: 30129713 [TBL] [Abstract][Full Text] [Related]
18. Immunization of mice with egG1Y162-1/2 provides protection against Echinococcus granulosus infection in BALB/c mice. Zhang F; Li S; Zhu Y; Zhang C; Li Y; Ma H; Pang N; An M; Wang H; Ding J Mol Immunol; 2018 Feb; 94():183-189. PubMed ID: 29328998 [TBL] [Abstract][Full Text] [Related]
19. Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate. Gan W; Zhao G; Xu H; Wu W; Du W; Huang J; Yu X; Hu X Parasitol Res; 2010 Mar; 106(4):873-82. PubMed ID: 20127115 [TBL] [Abstract][Full Text] [Related]
20. Echinococcus granulosus: immunoprotection accompanyied by humoral and cytokine response against secondary hydatidosis in mice immunized with rEg.myophilin. Sun J; Wang Y; Li Z; Ma R; Ji H; Xiong Y; Wang Y; Li Z; Zhao W Vet Res Commun; 2011 Apr; 35(4):193-200. PubMed ID: 21336572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]